Category Archives: DEA

US lawmakers urge feds to expand approved marijuana growers for research

Fifteen U.S. House lawmakers urged the heads of the Department of Justice and the Drug Enforcement Administration to expand the number of federally approved marijuana cultivators allowed to grow cannabis for research purposes. The request, made in an Oct. 1 letter, comes on the heels of the DEA granting approval to medical researchers at the […]

DEA reschedules epilepsy drug derived from marijuana

Epidiolex liquid CBD tincture. (Image from GW Pharma) A drug approved by the U.S. Food and Drug Administration (FDA) containing an ingredient found in cannabis will be reclassified for medical use. The Drug Enforcement Administration on Thursday placed the marijuana-derived drug Epidiolex in Schedule V of the Controlled Substances Act, reports CNBC. Epidiolex contains cannabidiol […]

FAQ: What to Know About the DEA’s CBD Rescheduling Order

For the first time ever, the Drug Enforcement Agency this week removed a cannabis-derived drug from Schedule I of the Controlled Substances Act. The change is a historic landmark on the path to ending cannabis prohibition, but it’s not nearly as sweeping as it might seem. RELATED STORY US Reschedules CBD Drug—but Not CBD Itself […]

DEA Reschedules Cannabis-Derived Medicine Epidiolex

The Drug Enforcement Administration has rescheduled the cannabidiol medication Epidiolex, allowing manufacturer GW Pharmaceuticals to begin selling the drug in the United States. The DEA did not, however, reschedule CBD itself nor other products made with the cannabinoid. Epidiolex is the first medication derived directly from cannabis to be approved by the Food and Drug […]

DEA proposes for more marijuana, less opioids in 2019

(courtesy Green Candy Press) Two federal agencies hope to reduce the nation’s opioid epidemic with the help of legal cannabis. In a news release issued by the Department of Justice and the Drug Enforcement Administration, officials are calling to quintuple the cultivation of research-grade cannabis while reducing production of the nation’s most frequently abused opioids. […]

Federal appeals court hears hemp industry lawsuit challenging DEA’s position on CBD

Published: Feb 15, 2018, 5:24 pm • Updated: Feb 16, 2018, 10:29 am By Alicia Wallace, The Cannabist Staff The fate of a federal rule viewed by hemp advocates as an existential threat to their emerging industry is now in the hands of a three-judge panel. The 9th U.S. Circuit Court of Appeals in San […]

Trial begins for advocates suing Sessions and the DEA over marijuana’s Schedule I status

Published: Feb 14, 2018, 11:03 am • Updated: Feb 14, 2018, 11:16 am By Karen Matthews, The Associated Press NEW YORK (AP) — Army veteran Jose Belen says the horrors of the Iraq War left him with post-traumatic stress disorder, and the drug that helped him cope best with the symptoms was one his Veterans […]